Enhanced RNA binding of dimerized aminoglycosides

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• RNA Therapeutics

Background:

• Aminoglycoside antibiotics are recognized as potent RNA-binding molecules.
• Understanding aminoglycoside-RNA interactions is crucial for designing novel RNA ligands.
• Existing knowledge on aminoglycoside-RNA recognition is insufficient for developing superior binders.

Purpose of the Study:

• To investigate the existence of multiple binding sites in large RNA molecules.
• To synthesize novel dimeric aminoglycosides for enhanced RNA binding.
• To compare the efficacy of dimeric versus monomeric aminoglycosides in inhibiting ribozyme function.

Main Methods:

• Synthesis of symmetrical and nonsymmetrical dimeric aminoglycosides.
• Comparison of dimeric and monomeric aminoglycosides' ability to inhibit the Tetrahymena ribozyme.
• Analysis of inhibition curves to infer binding site characteristics.

Main Results:

• Dimeric aminoglycosides exhibited 20 to 1.2 x 10(3)-fold greater inhibition of ribozyme function compared to monomeric forms.
• Inhibition curves suggested the presence of at least two high-affinity binding sites on the ribozyme.
• A model of dimeric aminoglycoside interaction with two complementary RNA sites was proposed.

Conclusions:

• Dimeric aminoglycosides represent a significant advancement in RNA-binding molecule design.
• The findings support the hypothesis of multiple high-affinity binding sites in large RNA structures.
• This research has implications for developing novel therapeutics targeting essential RNA molecules in pathogens.